Nvidia invests in four French startups, including Doctolib and Genesis AI

On Monday, 13 October 2026, Nvidia announced investments in four French startups, including the healthcare platform Doctolib and Genesis AI. The semiconductor company's total investment portfolio thus exceeds US$51 billion. Doctolib told Reuters that Nvidia will acquire a minority stake to support the development of AI tools.

Nvidia expands role as investor

In addition to Doctolib and Genesis AI, capital is also flowing into the two French companies Pigment and Entalpic. The investments underline Nvidia's strategic direction: the company is increasingly positioning itself as a capital provider for firms that rely on artificial intelligence and depend on Nvidia's chip technology.

Doctolib operates a digital platform for doctor's appointments and patient management. With Nvidia's stake, the development of AI-powered applications in the healthcare sector is to be accelerated. The French government recently promoted investments in AI startups to make the country more attractive as a location for technology companies.

Investment portfolio exceeds US$51 billion mark

Nvidia's investment portfolio now comprises more than US$51 billion. The company is thus pursuing a dual strategy: on the one hand, it secures access to emerging AI applications, and on the other, it binds customers to its chip architecture. Many of the invested startups use Nvidia's graphics processors for training and operating their AI models.

The investments in French companies come at a time when European governments are increasingly trying to build their own AI champions. France has positioned itself as a location for AI research and development and attracts international investors with tax incentives and funding programmes.

Doctolib stake in focus

Doctolib is one of France's leading providers of digital health services. The platform is used by millions of patients to book doctor's appointments and manage medical records. With Nvidia's support, the integration of AI features is to be accelerated, such as automated diagnosis assistance or optimisation of treatment processes.

Genesis AI, in turn, develops generative AI models for enterprise applications. Pigment offers a financial planning platform, while Entalpic operates in the field of AI-driven materials research. All four companies share intensive use of computing power provided by Nvidia's chips.

Nvidia as strategic partner in the AI ecosystem

Nvidia's role as an investor has grown in importance in recent years. The company strategically invests in companies that expand the AI ecosystem and simultaneously increase demand for Nvidia's hardware. The investments are often made through the company's own venture arm, which focuses on AI, robotics and data centre applications.

For the invested startups, the partnership with Nvidia means not only capital but also access to technical expertise and a global customer base. Nvidia often provides its partners with new chip generations early on and supports them in optimising software for its own hardware.